{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Congenital+Uterine+Anomaly", "query": { "condition": "Congenital Uterine Anomaly" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 72, "total_pages": 8, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Congenital+Uterine+Anomaly&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-07-24T11:20:07.496Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00005095", "title": "Specimen and Data Study for Ovarian Cancer Early Detection and Prevention", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cervical Cancer", "Endometrial Cancer", "Fallopian Tube Cancer", "Hereditary Breast/Ovarian Cancer (brca1, brca2)", "Ovarian Cancer", "Sarcoma", "Uterine Leiomyomata", "Vaginal Cancer", "Vulvar Cancer" ], "interventions": [ { "name": "Ca-125", "type": "OTHER" }, { "name": "screening questionnaire administration", "type": "OTHER" }, { "name": "Surgery", "type": "PROCEDURE" } ], "intervention_types": [ "OTHER", "PROCEDURE" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "FEMALE", "summary": "18 Years to 80 Years · Female only" }, "enrollment_count": 6000, "start_date": "2000-03", "completion_date": "2040-12", "has_results": false, "last_update_posted_date": "2025-02-28", "last_synced_at": "2026-07-24T11:20:07.496Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00005095" }, { "nct_id": "NCT07106359", "title": "Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cascade Testing", "Lynch Syndrome", "Decision Making", "Colorectal Cancer", "Uterine Cancer", "Cancer Prevention" ], "interventions": [ { "name": "Information Letter and Booklet", "type": "BEHAVIORAL" }, { "name": "Information Letter", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 185, "start_date": "2025-09-15", "completion_date": "2027-10-31", "has_results": false, "last_update_posted_date": "2026-07-21", "last_synced_at": "2026-07-24T11:20:07.496Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT07106359" }, { "nct_id": "NCT04851119", "title": "Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Colorectal Carcinoma", "Endometrial Carcinoma", "Melanoma", "Neuroblastoma", "Ovarian Carcinoma", "Pancreatic Ductal Adenocarcinoma", "Recurrent Desmoid Fibromatosis", "Recurrent Ewing Sarcoma", "Recurrent Hepatoblastoma", "Recurrent Hepatocellular Carcinoma", "Recurrent Malignant Solid Neoplasm", "Recurrent Non-Hodgkin Lymphoma", "Recurrent Osteosarcoma", "Refractory Desmoid Fibromatosis", "Refractory Ewing Sarcoma", "Refractory Hepatoblastoma", "Refractory Hepatocellular Carcinoma", "Refractory Malignant Solid Neoplasm", "Refractory Non-Hodgkin Lymphoma", "Refractory Osteosarcoma", "Solid Pseudopapillary Neoplasm of the Pancreas", "Wilms Tumor" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Dual X-ray Absorptiometry", "type": "PROCEDURE" }, { "name": "Tegavivint", "type": "DRUG" }, { "name": "X-Ray Imaging", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Months", "maximum_age": "30 Years", "sex": "ALL", "summary": "12 Months to 30 Years" }, "enrollment_count": 147, "start_date": "2021-11-08", "completion_date": "2028-06-30", "has_results": false, "last_update_posted_date": "2026-05-05", "last_synced_at": "2026-07-24T11:20:07.496Z", "location_count": 21, "location_summary": "Birmingham, Alabama • Los Angeles, California • Orange, California + 18 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04851119" }, { "nct_id": "NCT04652908", "title": "Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Myelomeningocele" ], "interventions": [ { "name": "Placental Mesenchymal Stem Cells seeded on a commercially available dural graft extracellular matrix", "type": "BIOLOGICAL" }, { "name": "Untreated contemporaneous cohort", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "University of California, Davis", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Weeks", "maximum_age": "25 Weeks", "sex": "ALL", "summary": "19 Weeks to 25 Weeks" }, "enrollment_count": 55, "start_date": "2021-06-21", "completion_date": "2027-03", "has_results": false, "last_update_posted_date": "2026-01-20", "last_synced_at": "2026-07-24T11:20:07.496Z", "location_count": 1, "location_summary": "Sacramento, California", "locations": [ { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04652908" }, { "nct_id": "NCT06096688", "title": "Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Colorectal Cancer", "Endometrial Cancer", "Hereditary Cancer Syndromes" ], "interventions": [], "intervention_types": [], "sponsor": "Weill Medical College of Cornell University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1120, "start_date": "2019-05-29", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2025-09-04", "last_synced_at": "2026-07-24T11:20:07.496Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06096688" }, { "nct_id": "NCT01701947", "title": "HEMOLEVEN® Expanded Access Program Prevention of Surgical/Postpartum Hemorrhage Severe Inherited Factor XI Deficiency", "overall_status": "NO_LONGER_AVAILABLE", "study_type": "EXPANDED_ACCESS", "phases": [], "conditions": [ "Wound; Rupture, Surgery, Cesarean Section", "Postpartum Hemorrhage", "Surgery" ], "interventions": [ { "name": "Hemoleven", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Laboratoire français de Fractionnement et de Biotechnologies", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "6 Months", "maximum_age": null, "sex": "ALL", "summary": "6 Months and older" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2013-08-23", "last_synced_at": "2026-07-24T11:20:07.496Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01701947" }, { "nct_id": "NCT06993844", "title": "Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Advanced Solid Tumors", "Advanced Breast Cancer" ], "interventions": [ { "name": "ETX-636 dose escalation", "type": "DRUG" }, { "name": "ETX-636 dose escalation in combination with fulvestrant", "type": "DRUG" }, { "name": "ETX-636 dose expansion in combination with fulvestrant", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ensem Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 233, "start_date": "2025-06-10", "completion_date": "2027-12-30", "has_results": false, "last_update_posted_date": "2026-06-23", "last_synced_at": "2026-07-24T11:20:07.496Z", "location_count": 10, "location_summary": "Newport Beach, California • San Francisco, California • New Haven, Connecticut + 6 more", "locations": [ { "city": "Newport Beach", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06993844" }, { "nct_id": "NCT06708429", "title": "Lynch Syndrome X-Talk of Enteral Mucosa With Immune System", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Lynch Syndrome", "Lynch Syndrome I", "Lynch Syndrome II", "Lynch Syndrome I (Site-specific Colonic Cancer)", "HNPCC", "HNPCC Gene Mutation", "Hereditary Cancer Syndrome", "Hereditary Cancer", "MLH1 Gene Mutation", "MLH1 Gene Deletion+Duplication", "MLH1 Loss of Expression", "MLH1 Gene Inactivation", "MSH2 Gene Mutation", "MSH2 Gene Deletion+Duplication", "MSH2 Loss of Expression", "MSH2 Gene Inactivation", "MSH6 Gene Mutation", "MSH6 Loss of Expression", "MSH6 Gene Inactivation", "PMS2 Gene Mutation", "PMS2 Gene Inactivation", "PMS2 Loss of Expression" ], "interventions": [ { "name": "LYNX EYE (Lynch syndrome X-Talk of Enteral mucosa with Immune System)", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "San Raffaele University", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2023-06-01", "completion_date": "2034-06-01", "has_results": false, "last_update_posted_date": "2026-04-24", "last_synced_at": "2026-07-24T11:20:07.496Z", "location_count": 1, "location_summary": "Monrovia, California", "locations": [ { "city": "Monrovia", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06708429" }, { "nct_id": "NCT02379494", "title": "First Trimester Prediction of Preeclampsia and Fetal Growth Restriction", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Preeclampsia", "Fetal Growth Restriction" ], "interventions": [], "intervention_types": [], "sponsor": "Fetal Medicine Foundation", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "18 Years to 50 Years · Female only" }, "enrollment_count": 1200, "start_date": "2013-03", "completion_date": "2017-01-01", "has_results": false, "last_update_posted_date": "2017-08-22", "last_synced_at": "2026-07-24T11:20:07.496Z", "location_count": 1, "location_summary": "Dayton, Ohio", "locations": [ { "city": "Dayton", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02379494" }, { "nct_id": "NCT02606045", "title": "Minimize Menorrhagia in Women With Von Willebrand Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Von Willebrand Diseases" ], "interventions": [ { "name": "recombinant von Willebrand factor", "type": "DRUG" }, { "name": "tranexamic acid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Margaret Ragni", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "13 Years to 45 Years · Female only" }, "enrollment_count": 39, "start_date": "2019-02-07", "completion_date": "2022-08-30", "has_results": true, "last_update_posted_date": "2024-07-01", "last_synced_at": "2026-07-24T11:20:07.496Z", "location_count": 19, "location_summary": "Gilbert, Arizona • Orange, California • San Francisco, California + 16 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Orange", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT02606045" } ] }